• Liesbeth ten Klooster, Coline H M van Moorsel, Peter Th W van Hal, Bernt van den Blink, George D Nossent, Erik A M Verschuuren, Johanna M Kwakkel-van Erp, Ed A van de Graaf, Diana A van Kessel, and Jan C Grutters.
• St. Antonius Ziekenhuis, Centrum voor Interstitiële Longziekten, afd. Longziekten, Nieuwegein, the Netherlands.
• Ned Tijdschr Geneeskd. 2012 Jan 1;156(2):A3752.

ObjectiveTo describe patients diagnosed with idiopathic pulmonary fibrosis (IPF) registered for lung transplantation and to evaluate the current referral guidelines for lung transplantation in the Netherlands.DesignRetrospective study.MethodAll patients diagnosed with interstitial lung disease and registered for lung transplantation from September 1989-June 2010 were included in this study. Patients who had been diagnosed with IPF according to the American Thoracic Society-European Respiratory Society criteria were included. Clinical data of these patients at the time of screening for lung transplantation and survival data were collected.ResultsIn total, 289 patients with IPF were registered for lung transplantation. After a first waiting list. During the waiting period, 30 patients (33%) died, 7 were taken off the list due to newly developed comorbidity and excessive physical deterioration, 51 underwent transplantation and 2 were still on the waiting list at the time of study closure. At the time of screening, the mean FVC% predicted of these patients was 51% (SD: 19.0) and the mean diffusing capacity was 27% of predicted (SD: 9.3).ConclusionOne-third of the IPF patients on the waiting list died before donor lungs became available. The mean diffusing capacity of 27% of predicted at the time of screening was considerably lower than advised in the international guidelines for placement on the waiting list. This study, therefore, shows that the timing of screening IPF patients for lung transplantation can be improved in the Netherlands.

19 keywords...

hide…